| Name | Necitumumab |
|---|
| Description | Necitumumab is a human IgG monoclonal antibody directed against EGFR. Necitumumab can be used for research of NSCLC, colorectal cancer, etc[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Garnock-Jones KP. Necitumumab: First Global Approval. Drugs. 2016 Feb;76(2):283-9. |
| No Any Chemical & Physical Properties |